First-line pembrolizumab in metastatic non-small cell lung cancer: A clinical text-mining analysis of effectiveness, costs, and trial eligibility

JAAD International · Elsevier

Аннотация

Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Hanieh Abedian-Kalkhoran, Hedwig M. Blommestein, Henk-Jan Guchelaar, Egbert F. Smit, Henk Codrington, Loes E. Visser, Juliëtte Zwaveling

Читать у издателя →

Похожие статьи